Proteomic analysis of serum extracellular vesicles reveals Fibulin-3 as a new marker predicting liver-related events in MASLD.
Sadatsugu SakaneHayato HikitaKumiko ShiraiTatsuya SakamotoRyohei NarumiJun AdachiNaruyasu KakitaYukinori YamadaHidenori ToyodaHirokazu TakahashiGoki SudaMachiko KaiYuki TahataRyotaro SakamoriShusuke KumazakiKenji FukumotoYuta MyojinKazuhiro MuraiTakahiro KodamaTomohide TatsumiTakeshi TomonagaNaoya SakamotoEiichi MoriiTetsuo TakeharaPublished in: Hepatology communications (2024)
Serum Fibulin-3 was identified as a biomarker for predicting liver-related events in patients with MASLD.
Keyphrases